Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)

doi:10.1016/j.breast.2012.06.013

The Breast

Volume 21, Issue 5, October 2012, Pages 678-681

https://doi.org/10.1016/j.breast.2012.06.013 Get rights and content

Under a Creative Commons license

open access

Viewpoints and debates

Sentinel lymph node biopsy (SLNB) is the standard approach for axillary staging in patients with early breast cancer. Recent data showed no outcome difference in patients with positive sentinel node between axillary dissection vs no further axillary surgery, raising doubts on the role of SLNB itself. Therefore, a new trial was designed comparing SLNB vs observation when axillary ultra-sound is negative in patients with small breast cancer candidates to breast conserving surgery.

Keywords

Sentinel lymph node biopsy (SLNB)

Breast cancer treatment

Ultra-sound

Axillary surgery

The Breast

Viewpoints and debateAbandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)

Viewpoints and debates

Keywords

Viewpoints and debate
Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)